
The U.S. Food and Drug Administration (FDA) announced Wednesday that it is taking steps aimed to foster the development of non-addictive alternatives to opioids to manage acute pain and prevent new addiction.
The agency issued draft guidance to provide recommendations to companies developing non-opioid analgesics for acute pain.